Next-generation sequencing (NGS) has reached unprecedented affordability and accessibility, catalyzing significant advancements in multiomics, spatial biology, and single-cell analysis. The declining costs of whole-genome sequencing empower researchers to explore complex biological questions that were previously unattainable, thereby enhancing our understanding of various diseases.
On April 29, 2026, the virtual summit titled The State of Multiomics & NGS, sponsored exclusively by Illumina, will showcase a distinguished lineup of experts discussing pivotal topics in the field. Attendees can expect rich insights into the latest NGS platforms, applications in neurodegenerative diseases, and critical data management strategies. This summit presents an invaluable opportunity for professionals in regulatory, QA/QC, CMC, and sourcing roles to stay abreast of cutting-edge developments and best practices.
Highlighted presentations include Dr. Miranda Orr’s keynote on spatial biology in Alzheimer’s research and discussions led by genomics veterans Dr. Keith Robison and Dr. Shawn Baker. With registration free of charge, the summit promises to be a key event for industry stakeholders seeking to leverage the latest in multiomics and NGS technology.
Open the full market picture for your next decision →
